Find Federal Grants
U.S. Mission to Saudi Arabia · PAS-RIYADH-FY23-01
U.S. Mission to Belgium · PAS-BE200-FY23-02
U.S. Mission to Belgium · PAS-BE200-FY23-01
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional)
National Institutes of Health · RFA-OD-23-005
Climate Resilience Centers
Office of Science · DE-FOA-0002915
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-007
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-006
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-011
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-010
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-002
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-005
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-004
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-003
Assisting Federal Facilities with Energy Conservation Technologies (AFFECT) 2022 Appropriations
Golden Field Office · DE-FOA-0002700
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
National Institutes of Health · RFA-CA-23-008
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-009
U.S. Mission to Guatemala · PAS-GUA-FY23-01
NOAA SBIR FY 2023 Phase I
Department of Commerce · NOAA-OAR-TPO-2023-2007691
U.S. Mission to Zambia · PAS-LUSAKA-AFCP-FY2023
Centers for Disease Control and Prevention - ERA · RFA-GH-23-003